Early- and late-onset neonatal sepsis

01OverviewDefinition, clinical context and the essential points that orientate the chapter.

Newborn immunity has limited innate and adaptive responses, immature barriers and small physiological reserve. Infection can progress rapidly while fever and localising signs remain absent.

Early-onset infection usually reflects organisms ascending before birth or acquired during delivery. Group B streptococcus and Escherichia coli are central pathogens, with risk shaped by gestation, membranes, maternal infection and intrapartum prophylaxis.

Late-onset infection includes community-acquired and healthcare-associated disease. Coagulase-negative staphylococci, Staphylococcus aureus, Gram-negative organisms and fungi become important in preterm babies with central lines, parenteral nutrition and prolonged admission.

The NICE framework separates background risk from clinical illness. One red flag or a combination of factors lowers the threshold for antibiotics, while an entirely well baby with only one non-red-flag factor may be closely observed for at least 12 hours.

Blood culture establishes pathogen and susceptibility but sensitivity falls with small volume and prior antibiotics. Document blood volume where possible and do not interpret a likely contaminant without the baby's state and device history.

CRP rises after inflammation begins and can remain low early. Serial values help stewardship, but culture, clinical trajectory and original level of suspicion must all support a stop decision.

Meningitis changes antibiotic choice, dose and duration. Lumbar puncture is postponed during cardiorespiratory compromise, shock, uncontrolled seizures, bleeding risk or signs suggesting raised intracranial pressure, but revisited promptly after stabilisation.

Aminoglycoside benefit depends on concentration while toxicity relates to accumulation. Exact gestation, postnatal age, weight, renal function, urine output and drug levels determine interval.

Prevention includes maternal GBS pathways, aseptic central-line care, hand hygiene, human milk, device removal when no longer required and antimicrobial stewardship.

Key points

Early-onset infection presents within 72 hours of birth in the NICE pathway and is commonly vertically acquired; late-onset infection begins from 72 hours onward.
Neonatal sepsis is often nonspecific: altered behaviour, poor feeding, temperature instability, respiratory change, apnoea, jaundice, glucose instability or abdominal signs may precede collapse.
Use NICE risk factors and clinical indicators systematically. Any red-flag indicator, or two or more non-red-flag factors or indicators, usually triggers investigation and empirical antibiotics.
Obtain blood culture before the first dose whenever possible, but never delay antimicrobials in an unwell baby. Give antibiotics within 1 hour of the treatment decision.
First-line early-onset empirical treatment is IV benzylpenicillin 25 mg/kg every 12 hours plus gentamicin 5 mg/kg, with the next gentamicin dose usually 36 hours later and guided by levels.
Consider benzylpenicillin every 8 hours when the baby appears very ill. Doses and intervals must follow gestation, age, renal function and the current neonatal formulary.
For suspected late-onset infection in a neonatal unit, NICE recommends a narrow-spectrum combination such as IV flucloxacillin plus gentamicin, modified by local surveillance.
If meningitis is suspected and the organism is unknown, NICE recommends IV amoxicillin plus cefotaxime. Perform lumbar puncture when safe without delaying treatment.
Measure baseline CRP and repeat 18–24 hours after presentation. A single low CRP cannot exclude infection; trajectory and clinical course support review.
Consider stopping early-onset antibiotics at 36 hours and late-onset antibiotics at 48 hours only when culture is negative, initial suspicion was not strong, the baby is clinically reassuring and CRP trend is reassuring.
Treat a positive blood culture or strongly suspected sepsis without meningitis for 7 days in most cases; extend for pathogen, site, recovery or microbiology advice.
Source control matters: remove or replace an infected line when indicated, drain collections and investigate focal bone, joint, urinary, skin or abdominal infection.

02AetiologyUnderlying causes, associations and risk factors, with why each one matters.

Vertical early infection

GBS, E. coli and other maternal genital or enteric organisms ascend through membranes or are acquired during birth.

Healthcare-associated late infection

Central lines, ventilation, parenteral nutrition and prolonged admission expose preterm infants to staphylococci, Gram-negative organisms and fungi.

Community late infection

GBS, enteric organisms, respiratory viruses, HSV and focal urinary, skin or bone infection can present after discharge.

Host susceptibility

Prematurity, impaired barriers, limited maternal antibody and invasive devices reduce containment and permit rapid bloodstream spread.

03PathophysiologyThe causal sequence from the underlying abnormality to symptoms and harm.

1
Dysregulated inflammation
Pathogen sensing triggers cytokine and endothelial activation, capillary leak and vasodilation, compromising perfusion and gas exchange.
2
Limited neonatal reserve
Small cardiac, glucose and respiratory reserves turn modest physiological disturbance into apnoea, shock and metabolic instability.
3
Blood-brain invasion
Bacteraemia can cross immature barriers, producing meningitis, cerebral inflammation, seizures and later hearing or developmental injury.
4
Coagulation and organ injury
Severe inflammation activates coagulation and impairs kidney, liver, lung, brain and gut perfusion, sometimes causing DIC and NEC.

04Clinical features and red flagsSymptoms, examination findings, patterns of presentation and time-critical warnings.

Maternal infection history

Ask about maternal GBS, fever, suspected chorioamnionitis, membrane duration, preterm labour, intrapartum antibiotics, previous affected infant and antenatal infection results.

Neonatal examination

Assess behaviour, feeding, cry, tone, temperature, respiratory effort, apnoea, colour, perfusion, heart rate, glucose, abdomen, skin, umbilicus, joints and neurological state.

Onset and setting

Classify onset from birth time and identify whether infection is community or neonatal-unit acquired because empirical organisms and antibiotic choices differ.

Focal source

Review all lines, wounds and devices and inspect for cellulitis, pustules, discharge, joint immobility, abdominal signs and focal respiratory findings.

Parental observation

Treat parental report of a baby being unusually sleepy, cold, feeding poorly or breathing differently as clinically meaningful even if one observation is normal.

NICE classification

Document each NICE risk factor and clinical indicator explicitly, including whether it is a red flag and the resulting observation or treatment decision.

Red flags requiring action

Apnoea, grunting, increasing oxygen need, shock, mottling, poor perfusion or hypotension may be the only early sign of invasive infection.
Seizure, bulging fontanelle, abnormal tone, reduced responsiveness or unexplained temperature instability raises meningitis and requires an appropriate CNS-penetrating regimen.
Rapidly spreading non-blanching rash, bleeding or severe thrombocytopenia raises disseminated infection and coagulopathy.
Bilious aspirate, marked abdominal distension, blood in stool or abdominal discoloration raises necrotising enterocolitis with or without sepsis and requires feeds to stop.
Maternal fever, clinical chorioamnionitis, invasive group B streptococcal infection in a previous baby or prolonged membrane rupture materially alters early-onset risk.
Central-line infection, focal skin or joint findings, poor feed tolerance or a new apnoea cluster in a neonatal-unit infant can be late-onset infection despite subtle systemic signs.

05InvestigationsWhat to request, why it matters and how to interpret it.

Investigation order

Read from the initial assessment onwards. Tests may run in parallel in urgent care; first-line, preferred, confirmatory, definitive and gold-standard labels appear only when the chapter explicitly states them.

01
First-line: blood culture before antibioticsFirst stepFirst line
Why
Identify bacteraemia and guide narrow definitive treatment.
Interpretation and limitations
Collect an adequate sample before the first dose when this does not delay care; interpret organism, time to positivity, line status and clinical findings together.
02
Baseline and 18–24-hour CRP
Why
Support diagnosis and antibiotic review alongside culture and clinical trajectory.
Interpretation and limitations
An early normal result does not exclude sepsis. A reassuring trend contributes to, but cannot alone determine, stopping at 36 or 48 hours.
03
Blood gas, lactate, glucose, FBC, renal and liver profile
Why
Assess shock, metabolic instability, cytopenia and organ dysfunction and prescribe safely.
Interpretation and limitations
Thrombocytopenia, acidosis, hypoglycaemia or high lactate can mark severity but are not pathogen-specific; renal function affects gentamicin dosing.
04
Reference standard for meningitis: CSF microscopy, protein, glucose, culture and PCRReference standard
Why
Confirm CNS infection and define organism and duration.
Interpretation and limitations
Perform before antibiotics if safe and without delay; otherwise treat first and sample after stabilisation. Interpret values using gestation and postnatal age.
05
Urine culture and focal cultures
Why
Identify late-onset urinary, skin, line or other focal infection.
Interpretation and limitations
Urine testing is not routine in early-onset assessment but is important in late-onset disease; use a contamination-minimising collection method.
06
Imaging for a focus
Why
Detect pneumonia, NEC, abscess, osteomyelitis, septic arthritis or complications of meningitis.
Interpretation and limitations
Select chest/abdominal imaging, ultrasound or MRI from clinical findings; imaging should not postpone antibiotics in systemic illness.

06Differential diagnosisRealistic alternatives and the features that help distinguish them.

Respiratory or cardiac transition disease

RDS, TTN, PPHN and congenital heart disease can mimic sepsis through oxygen need, tachypnoea and poor perfusion.

Metabolic or endocrine disease

Hypoglycaemia, electrolyte disorders, inborn errors and adrenal disease cause feeding, tone, temperature and circulatory abnormalities in newborns.

Neurological or drug-related disorder

HIE, intracranial haemorrhage, seizures and maternal medicine exposure may produce neonatal apnoea, hypotonia, feeding difficulty and altered behaviour.

Surgical abdominal disease

Malrotation, obstruction, perforation and NEC require urgent neonatal surgical assessment when bilious vomiting or progressive abdominal signs dominate.

07ManagementImmediate care, first-line treatment, alternatives and escalation.

01Early onsetRisk and indicator decisionFirst stepThe baby is within 72 hours of birth.

1Identify red flags and count other NICE risk factors and clinical indicators.
2With any red flag or at least two factors/indicators, culture and treat without waiting; with only one non-red-flag item, use clinical judgement and monitor for at least 12 hours if not treating.
3Reassess immediately if a new indicator emerges.

02Empirical treatmentCulture then antibioticsAntibiotics are indicated for suspected sepsis.

1Obtain blood culture and baseline CRP promptly, plus CSF if indicated and safe.
2Give the onset- and setting-appropriate IV regimen within 1 hour and use neonatal independent dose checks.
3Stabilise organs, monitor levels and refine therapy when pathogen, focus and susceptibilities become known.

03Antibiotic reviewStop safely or complete treatmentCultures and serial clinical data are available.

1At 36 hours for early onset or 48 hours for late onset, review culture, original suspicion, current examination and CRP trend.
2Stop only when every NICE reassurance criterion is met; otherwise continue and document daily justification when cultures remain negative.
3Treat positive or strongly suspected sepsis usually for 7 days, extending for organism, focus, meningitis or slow recovery.

04MeningitisCNS-penetrating treatmentNeurological signs, positive culture or clinical course raises meningitis.

1Stabilise and perform lumbar puncture when safe; do not delay empirical therapy.
2Use IV amoxicillin plus cefotaxime while the organism is unknown and obtain microbiology advice.
3Narrow when identified and arrange hearing and neurodevelopmental follow-up.

Key medicines and prescribing safety4 treatments · regimens, roles and cautions

First-line narrow beta-lactam component for suspected early-onset neonatal infection under NICE NG195.

Benzylpenicillin intravenous

For empirical early-onset infection, 25 mg/kg IV every 12 hours; consider every 8 hours when the newborn appears very ill. Pair with gentamicin and use the current neonatal formulary for gestation, age and renal modifiers.

Check allergy, renal function and exact weight. This empirical dose is not the meningitis dose. Review at 36 hours and narrow or stop only when NICE criteria are met.

First-line aminoglycoside partner for early-onset infection and a component of narrow late-onset neonatal-unit regimens.

Gentamicin intravenous

5 mg/kg IV for empirical neonatal infection. NICE advises the second dose usually 36 hours later in early-onset treatment; all subsequent timing follows concentration monitoring, gestation, postnatal age, renal function and the neonatal formulary.

Obtain and act on levels, monitor creatinine and urine output, and avoid concurrent nephrotoxic or ototoxic exposure where possible. Interval errors are dangerous; do not default to adult schedules.

NICE example of a narrow-spectrum anti-staphylococcal component for late-onset neonatal-unit infection.

Flucloxacillin intravenous

Use the current weight-, gestation- and postnatal-age dose from the neonatal formulary, combined with gentamicin for suspected late-onset infection in a neonatal unit where local surveillance supports this regimen.

Local resistance and previous colonisation determine suitability. Adjust for renal function and investigate line or skin source; this combination is not adequate empirical meningitis treatment.

First-line empirical CNS-penetrating combination in NICE NG195 while culture and PCR define the pathogen.

Amoxicillin plus cefotaxime intravenous

When neonatal meningitis is suspected and the organism is unknown, give both agents at the exact meningitis doses and intervals specified by the current neonatal formulary for gestation, postnatal age, weight and renal function.

Do not delay for lumbar puncture if unstable. Avoid routine ceftriaxone in neonates because of bilirubin displacement and calcium interaction; seek microbiology advice and narrow promptly.

08ComplicationsImportant consequences, why they occur and why they matter clinically.

Shock and multiorgan failure

Capillary leak, myocardial dysfunction and disordered vascular tone can progress to renal, hepatic, respiratory and coagulation failure.

Meningitis sequelae

Hearing loss, seizures, hydrocephalus, cerebral palsy and cognitive impairment can follow neonatal meningitis despite apparently adequate antimicrobial treatment.

Focal infection

Osteomyelitis, septic arthritis, abscess, endocarditis or urinary disease may require longer targeted therapy, imaging and effective source control.

Treatment harm

Aminoglycoside toxicity, line complications, altered microbiome, fungal disease and resistance rise with unnecessary or poorly monitored treatment.

09Monitoring and follow-upTreatment response, safety checks and longer-term review.

Continuously monitor temperature, heart rate, respiratory status, saturation, perfusion, blood pressure, urine output, glucose and neurological state in an unwell baby.
Record exact antibiotic dose and administration time; treatment should begin within 1 hour of the decision.
Measure gentamicin concentrations and adjust interval through the current neonatal formulary using renal function, urine output and gestational and postnatal age.
Repeat CRP at 18–24 hours and review culture status actively at the laboratory's 36- or 48-hour milestone.
Trend FBC, coagulation, renal and liver function and lactate according to severity and medicine toxicity.
Inspect and reassess every possible focus and device; pursue source control and narrow antibiotics once susceptibility is known.
After meningitis or severe sepsis arrange formal hearing assessment, neurological and developmental follow-up and family safety-netting.

10Special situationsVariants, exceptions and circumstances that change the usual approach.

Cold can be sepsis

Neonates may be hypothermic rather than febrile, and a normal temperature does not exclude invasive infection.

The clock follows the decision

NICE expects administration within 1 hour once treatment is chosen; culture collection and prescribing systems must work inside that window.

One CRP is not a rule-out

A baseline sample may precede the inflammatory rise; serial change is interpreted with culture and examination.

Meningitis can lack a bulging fontanelle

Apnoea, irritability, altered tone, poor feeding or seizures may be the only neurological clues in a newborn.

Stewardship is active care

A scheduled 36- or 48-hour review prevents unnecessary exposure but stopping requires all reassurance criteria, not culture status alone.

11Common pitfallsFrequent interpretation and management errors.

01
Do not wait for fever or a raised CRP before treating an ill newborn.
02
Do not delay antibiotics beyond 1 hour while attempting lumbar puncture or imaging.
03
Do not use a late-onset neonatal-unit regimen for early vertical infection without a reason.
04
Do not prescribe gentamicin interval from dose memory without gestation, age, renal function and level planning.
05
Do not stop solely because blood culture is negative.
06
Do not continue culture-negative antibiotics without daily documented clinical and biomarker justification.
07
Do not overlook NEC, HSV, enterovirus, congenital infection or a surgical focus when antibacterial treatment fails.
08
Do not discharge after serious infection without hearing, development and recurrence safety-netting appropriate to the focus.